Client: a company that has always been involved in the research, development and marketing of innovative medicines.
Sector: Pharmaceuticals
Objective: to validate a number elements affecting the systems, specifically the points
of use (end point of a distribution network) of utilities serving production, i.e. water, gaseous/liquid nitrogen and compressed air
The client company is a leading international chemical-pharmaceutical producer, engaged for decades in the development of new medicines, the introduction of cutting-edge technologies and innovative health management practices.
The client needed to validate certain elements affecting the plants, specifically the points of use (end point of a distribution network) of the utilities serving production, namely water, gaseous/liquid nitrogen and compressed air.
This criticality was supported by a preliminary risk analysis process in accordance with directive ICH Q9 Quality Risk Management – November 2005.
The choice of points to be monitored (whether new or existing) was then justified and based on the analytical results it was possible to predict a periodic monitoring plan guaranteeing the quality of the points of use in accordance with current regulations and the customer’s internal specifications.
This activity required a considerable commitment and specific expertise from a
technical, documentary, and regulatorypoint of view. For this reason, the client turned to an external service provider.
On the basis of the reference legislation (Official Pharmacopoeia, GxP, Edralex) and internal procedures, the work team analysed the requirements envisaged by the project and prepared a Risk Analysis document in accordance with the FMEA methodology to establish points-of-use criticality.
Once the points of use with a medium/high criticality level (i.e. with a significant risk of contamination of the product or materials) were identified, it was possible to choose which ones to sample and therefore which ones to submit to the chemical/microbiological analyses provided for in the validation protocol.
At the end of the qualification phase for the points of use, a Periodic Monitoring Plan was developed, in which, through a further Risk Analysis process, the points of use to be included in the routine sampling (periodic analyses) were defined.
The project included the installation of both new points of use and modifications to existing points of use; the planned activities originated from several existing projects including: construction of a new laboratory, construction of a new granulation area, and revamping of pre-existing areas.
The complexity of projects related to utility validation activities has required several months of work and continuous collaboration with the various departments of the client company, including the Quality, the Validation, the Production and, the Engineering departments and the chemical and microbiological Laboratories; the need to interface with the company’s different operational areas has highlighted S4BT’s ability to adapt to any context and to establish fruitful cooperation with all work teams
The project contributed to the implementation of a Risk Analysis process which had not been in place until then.
Furthermore, the analysis served as the initial basis of a process aimed at eliminating the numerous microbiological and chemical samplings required from the respective laboratories.
The completed work laid the foundations for a controlled management of sampling plans and analysis in accordance with the current QRM.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit
Pharmaceutical Company
An international pharmaceutical organisation specialising in the clinical and commercial development and production of pharmaceutical products with a high degree of toxicity.
Digital Company
Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar
Petshop Company
Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar
Conditioner Company
Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar
Card Rental
Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar
Expedition Company
Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar
TOGETHER IS BETTER.
Simplify the management of Complaints, from filing, through investigation, follow-up, judgment and final report.
The module is designed to provide step by step Quality Assurance support
in the implementation and supervision of the process and the assignment of tasks to the departments involved. The module supplements the CAPA procedure, which the user can open directly from the Complaints procedure.
PRAGMA-WFM documents and traces all activities and information in the Complaints process. In each phase, you can also attach files in various formats to support activities and investigations.
During inspection phases, the functionality dossier enables the real-time generation of a document that provides information and lists the activities of the process and related processes
It simplifies the management of internal and external audits, from planning, through execution, to the management of remarks.
The module supplements procedures for handling CAPAs , Non Conformitiesand Change Control that the user can open directly from the audit to resolve the observations found.
PRAGMA-WFM documents and traces all activities and information of the Audit process. For each process step, it is possible to assign tasks to the people involved, and attach files in various formats.
Duringthe inspection phase, the dossierfunctioncan generate a document in real time which records the information and activities of the Audits and related processes